Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefopam/Paracetamol FDC for Acute Dental Pain
NCT04622735Phase 3Completed
- Sponsor
- Unither Pharmaceuticals
- Start
- Feb 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of nefopam, acetaminophen in acute pain, sponsored by Unither Pharmaceuticals. Started Feb 2020; status: completed.
02
Drugs
nefopamacetaminophen
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT04622735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04622735.